Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04093713
Other study ID # Surg192
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date September 14, 2019
Est. completion date September 16, 2019

Study information

Verified date September 2019
Source Hosh Isa Medical Center
Contact Mosaad A Khalifah, DDSc
Phone 00201008603084
Email mosaad78@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study introduces and evaluates a new technique for inferior alveolar nerve blocking.


Description:

The study addresses a novel technique to anaesthetize the inferior alveolar nerve depending on extraoral landmarks. Volunteers will receive bilateral blocks and evaluation of the success rate and positive aspiration rate will be performed.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 65
Est. completion date September 16, 2019
Est. primary completion date September 16, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 5 Years to 55 Years
Eligibility Inclusion Criteria:

- fitness for nerve block local anaesthesia physically and psychologically

Exclusion Criteria:

- any disease or condition obstacles nerve block local anaesthesia administration such as hemophilia.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
A novel technique to block the inferior alveolar nerve block using Mepivecaine with Levonordefrin
blocking the inferior alveolar nerve using extroral landmarks

Locations

Country Name City State
Egypt Hosh Isa Medical Center Hosh Isa Al-Behera

Sponsors (1)

Lead Sponsor Collaborator
Mosaad Khalifah

Country where clinical trial is conducted

Egypt, 

References & Publications (7)

Akinosi JO. A new approach to the mandibular nerve block. Br J Oral Surg. 1977 Jul;15(1):83-7. — View Citation

Boonsiriseth K, Sirintawat N, Arunakul K, Wongsirichat N. Comparative study of the novel and conventional injection approach for inferior alveolar nerve block. Int J Oral Maxillofac Surg. 2013 Jul;42(7):852-6. doi: 10.1016/j.ijom.2012.11.017. Epub 2012 Dec 21. — View Citation

Donkor P, Wong J, Punnia-Moorthy A. An evaluation of the closed mouth mandibular block technique. Int J Oral Maxillofac Surg. 1990 Aug;19(4):216-9. Review. — View Citation

Kanaa MD, Whitworth JM, Corbett IP, Meechan JG. Articaine buccal infiltration enhances the effectiveness of lidocaine inferior alveolar nerve block. Int Endod J. 2009 Mar;42(3):238-46. doi: 10.1111/j.1365-2591.2008.01507.x. — View Citation

McLean C, Reader A, Beck M, Meryers WJ. An evaluation of 4% prilocaine and 3% mepivacaine compared with 2% lidocaine (1:100,000 epinephrine) for inferior alveolar nerve block. J Endod. 1993 Mar;19(3):146-50. — View Citation

Montagnese TA, Reader A, Melfi R. A comparative study of the Gow-Gates technique and a standard technique for mandibular anesthesia. J Endod. 1984 Apr;10(4):158-63. — View Citation

Suazo Galdames IC, Cantín López MG, Zavando Matamala DA. Inferior alveolar nerve block anesthesia via the retromolar triangle, an alternative for patients with blood dyscrasias. Med Oral Patol Oral Cir Bucal. 2008 Jan 1;13(1):E43-7. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary presence of numbness (by questionnaire) evaluation of the presence of numbness in the anatomical area supplied by the inferior alveolar nerve 3-10 minutes
Primary absence of pain (by probing) evaluation of absence of pain in the anatomical area supplied by the inferior alveolar nerve 3-10 minutes
Secondary positive aspiration rate evaluation of the presence of blood on drawing in two perpendicular planes 1 second
See also
  Status Clinical Trial Phase
Completed NCT03428282 - Pain and Anxiety Control During Traditional Mandibular Anesthesia in Children Using Distracting Tools N/A
Active, not recruiting NCT01870232 - Evaluation of Use of Ultrasound for Greater Palatine Nerve Block and Inferior Alveolar Nerve Blocks: An Open Label Feasibility Study N/A